Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
"Vaccination of girls against HPV, screening, and treatment of pre-cancer lesions, and improved access to diagnosis and treatment of invasive cancers are critical, cost-effective measures that policy makers should urgently apply to eliminate cervical cancer as a public health problem"
Dr. Poonam Khetrapal Singh,
Regional Director,
WHO South-East Asia
Sponsor
Patient Safety Capsules
India producing medical devices at one-third of world price: Union Minister
New Delhi, November 17, 2022: India is among the top five countries in the world manufacturing life-saving high risk medical devices and the cost of the Indian devices is about one-third of those manufactured by some of the other countries, said Union Minister for Science and Technology Dr Jitendra Singh.
Health ministry includes coronary stents in NLEM 2022
New Delhi, November 15, 2022: The Union ministry of health and family welfare (MoHFW) has notified inclusion of Coronary Stents in the National List of Essential Medicines (NLEM), 2022, with immediate effect based on the recommendations by the expert committee constituted to review and revise the list based on requirement.
Drug Laws & Policy Injections
DoP amends DPCO, 2013 to include NLEM 2022 into Schedule I
New Delhi, November 15, 2022: The Department of Pharmaceuticals (DoP) has issued a notification amending the Drugs (Prices Control) Order, 2013, in order to replace the previous version of National List of Essential Medicines (NLEM) with NLEM, 2022, which was launched in September, this year by the Union health minister Dr MansukhMandaviya. 
DoP rejects review application by Win Medicare against NPPA’s price fixation of hand rub product
New Delhi, November 17, 2022: The Department of Pharmaceuticals (DoP) has rejected a review application filed by Delhi-based Win Medicare Pvt Ltd in connection with the price fixation by National Pharmaceutical Pricing Authority (NPPA) for its hand rub product.
Maha FDA to take stern action against bodybuilders involved in misuse of prescription drugsNew Delhi, November 17, 2022: The Maharashtra Food and Drug Administration (FDA) said that stern action will be taken against bodybuilders involved in misuse of prescription drugs.
Experts urge DCGI to direct state DCs for action against altering components without changing brand names
Chennai, November 16, 2022: Health activists and a group of retired enforcement officers from across the country have urged the Drugs Controller General of India (DCGI) to issue a direction to the state regulators and the CDSCO’s zonal offices to act on the circular the DCGI issued on May 16, 2019 for legal action against manufacturers who alter the contents of formulations without changing the brand names.
Delhi HC settles dispute on territorial jurisdiction of patent appeals post abolition of IPAB
New Delhi, November 12, 2022: Putting an end to a dispute on the territorial jurisdiction of patent appeals following the abolishment of the Intellectual Property Appellate Board (IPAB),
PCI asks institutions to go through and comply with SC orders for approvalsNew Delhi, November 14, 2022: The Pharmacy Council of India (PCI) has sought all the institutions to go through the recent Supreme Court order and to comply with it for applying for approval of institutions.
Pharma Injections
Pharma MNCs looking to capitalize on opportunities in Indian medical technology sector
Mumbai, November 12, 2022: Multinational pharmaceutical companies are looking to capitalize on opportunities in the Indian medical technology sector resulting from rapid growth in the healthcare sector due to increased government initiatives and public awareness of health issues.
Pharma industry sees US FDA human gene therapy for neurodegenerative diseases to propel new treatment options
Bengaluru, November 12, 2022: Pharma industry sees that the US FDA guidance on human gene therapy for neurodegenerative diseases will help to propel new treatment options. It focuses on factors to be considered for product development, preclinical testing, and clinical trial design.
Indian pharma evinces interest for SCF as efficient and cost-effective way to improve cash flowsBengaluru, November 17, 2022: Indian pharma is evincing keen interest in supply chain finance (SCF) with top pharma firms seeing a relatively faster cash conversion cycles in the past. Hence, most prefer managing working capital at an enterprise level.
MSF releases clinical trial transparency policy to promote equity in biomedical R&D ecosystem
Mumbai, November 15, 2022: In a bid to bring transparency in clinical trial costs which will in turn increase equity in the biomedical R&D ecosystem, Médecins Sans Frontières (MSF), a global medical non-governmental organization, has approved and published its first Clinical Trial Transparency Policy (CTTP).
50 million doses of Covaxin set to expire early 2023
November 7, 2022: About 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin, lying with the firm, are set to expire early next year as there are no takers owing to poor demand, company sources said.
IMPCL registers threefold increase in its profits of Rs 45.41 crore for FY 21-22NEW DELHI, 16 November 2021: The Indian Medicines Pharmaceutical Corporation (IMPCL), a Central Public Sector Enterprise (CPSE), under the Ministry of AYUSH, has announced to pay a dividend of Rs 10.13 crore to its stakeholders – Ministry of AYUSH and Government of Uttarakhand.
Drug Dopes
World Diabetes Day: WHO calls for increased access to diabetes education
November 14, 2022: The World Health Organisation (WHO) on Monday called for increased access to quality diabetes educa-tion for healthcare workers, the public and people living with diabetes as part of efforts to ensure better access to quality and affordable care for the disease. 
Pneumoniais the single biggest infectious killer of adults and childrenNovember 12, 2022 : Pneumonia is a serious, potentially life-threatening lung infection that can strike both children and adults. It is the single biggest infectious killer of adults and children, with an annual mortality rate of roughly 2.5 million adults and children globally. India accounts for 23 per cent of global pneumonia burden with fatality rates between 14 and 30 per cent. This infection is increasingly common among children, the elderly and those with comorbidities like COPD, diabetes mellitus, renal failure, congestive heart failure, chronic lung disease, etc.
Rising air pollution can affect unborn babies, pregnant women need to take care: ExpertsNovember 10, 2022: As the air quality deteriorates in Delhi-NCR, health experts are of the view that air pollution can negatively affect pregnancy, possibly leading to preterm birth, a low birth weight, stillbirth, or congenital abnormalities.
Ophthalmologists see treatment for vision loss in diabetic retinopathy as major challenge with no drugs & late diagnosisBengaluru, November 14, 2022: Ophthalmologists see treatment of vision loss in diabetic retinopathy as major challenge with no drugs and late diagnosis. Diabetic retinopathy is the leading cause of blindness among adults worldwide, including in developing countries such as India.
IPC set to harmonise 31 general chapters & as many excipient monographs of IP with PDG in three phasesMumbai, November 12, 2022: The Indian Pharmacopoeia Commission (IPC) is set to harmonize 31 general chapters and as many excipient monographs of Indian Pharmacopoeia (IP) with Pharmacopoeial Discussion Group (PDG) in three phases. The first phase will start from December 2024 and the last phase from December 2028.
DBT releases guidelines for career advancement and re-orientation programme for women scientistsNew Delhi, November 16, 2022: The Department of Biotechnology (DBT) has released the guidelines for the implementation of research projects under the Biotechnology Career Advancement and Re-orientation (BioCARe) programme for women scientists, including in the field of medical biotechnology or allied areas. It has called for Letter of Intents under the scheme for women scientistsupto age of 55 years, aiming at career development of unemployed/not in regular position women scientists.
National Injections
Karnataka to distribute 1 croreAyushman Bharat cards by December to ensure access to affordable healthcareBengaluru, November 16, 2022: Karnataka government is now working to distribute over 1 croreAyushman Bharat-Arogya Karnataka (AB-ARK) cards, which cover 50% of the eligible population in the state, by December.
Goa chapter of WAC & AMMOI to host 9th World Ayurveda Congress &Arogya Expo in Goa from Dec 8-11
Chennai, November 12, 2022: The Goa chapter of the World Ayurveda Foundation (WAF) in association with AMMOI will host the 9th World Ay-urveda Congress (WAC) and Arogya Expo at Panaji in Goa from December 8 to 11.
Odisha govt dissolves state pharmacy council
Chennai, November 15, 2022: The Government of Odisha has dissolved the state pharmacy council (OSPC) and debarred all the present council members from attending the council meeting stating that they are no more members of the OSPC.
Govt incentives spur Karnataka to second spot in number of Jan AushadiKendras
Bengaluru, November 15, 2022: Karnataka stands second in the country in the number of Jan AushadiKendras which sell generic drugs at subsidized rates. The key factors that have driven the state to the second position is the ample support from the central and state governments.
VAP asks govt to direct NCISM to withdraw denial of permission to admit students for BAMS at A L Govt Ayurvedic College in WarangalChennai, November 14, 2022: Following denial of permission to admit students for the degree course Bachelor of Ayurveda Medicines and Surgery (BAMS) to the A L Government Ayurvedic College at Warangal by the National Commission for Indian System of Medicines (NCISM), the Telangana chapter of the Vishwa Ayurveda Parishad (VAP) has appealed to the Union Minister of Ayush to immediately intervene into the matter to save the institution from the crisis.
Measles outbreak: Centre rushes medical team to Mumbai
Mumbai, November 10, 2022: The Union Health Ministry on Wednesday rushed a team of experts from different medical fields to Mum-bai after the report of measles outbreak and deaths of three children.
Global Injections
Peru withdraws health emergency & national emergency making Indian pharma export costlyMumbai, November 14, 2022: The Peruvian government has withdrawn national state of emergency and health emergency restoring tariff duties on the 77 products ranging from chemicals, pharmaceuticals and medical devices.
US hospital flu cases hit 10-year high as vaccinations fall
November 5, 2022: US influenza hospital admissions have hit the highest rate in a decade as vaccinations sag, US officials say. They said adults have received five million fewer influenza jabs this year compared with the same time last year.
Buzz Kill: Lung Damage Looks Worse in Pot SmokersNovember 15, 2022: Scans of the lungs of pot users have turned up an alarming surprise: Regular smokers of marijuana ap-pear to be at greater risk for lung damage than people who smoke tobacco alone.
Long Hours at Day Care Don't Worsen Young Kid's Behavior: Study
November 16, 2022: Working parents will be relieved to know that young children who spend extended hours in childcare cen-ters are not at greater risk for behavior problems.
FDA reprimand for troubled Indian manufacturer LupinNovember 16, 2022: The hits just keep on coming for India manufacturing giant Lupin as it continues to run afoul of the FDA. In a regulatory filing late last month with the Bombay Stock Exchange, the drugmaker said it received a Form 483 notice from the FDA citing problems at its injectables facility in Nagpur. The notice flagged five observations and came after a preapproval inspection of the site from Oct. 17 to Oct. 29.
Germany’s BioNTech says to set up mRNA vaccine facility in SingaporeNovember 14, 2022 : BioNTech SE has acquired a manufacturing facility in Singapore, its first in Asia, the company said today. The facility, bought from a Novartis unit, will be its first messenger ribonucleic acid, or mRNA, facility in Singapore and support its vaccines production for the Asia Pacific region, BioNTech said in a statement, without disclosing financial details.
PSAIIF PILL
MTaI urges govt to reduce high customs duty and additional health cess on medical devices
New Delhi, November 14, 2022: Appreciating the Central government’s key measures in the first half of the current fiscal year to support the industry, the research-based medical technology companies have expressed their hope that the government considers reducing the high customs duty and additional health cess levied on medical device imports.
Tripartite agreement signed to give boost to pharma project in Pondicherry
Chennai, November 17, 2022: The government of Pondicherry, which has been trying to establish one pharma park to give a boost to the local manufacturing units, has now signed a tripartite agreement between health department, education department and industry department for setting up an Integrated Green Pharmaceutical Innovation Research Park at Sedrapet.
Frequently Asked Questions
How dangerous is it to ignore borderline sugar that is prediabetes?
November 14, 2022: Borderline diabetes (prediabetes) is the stage when the person gets type 2 diabetes. It happens due to impaired fasting glucose or glucose even intolerance. It means the blood sugar levels are not in the rec-ommended range but not that high to term it diabetes. Ignoring it is a strict no-no as there are many com-plications related to it. In the below article, we tell you about the causes, signs, and dangers of borderline sugar.Read More>>>
SUBSCRIBER'S SYMPTOM
Ways to control Type 1 and Type 2 Diabetes levels among kids
November 14, 2022: Diabetes mellitus is a chronic metabolic disease requiring long term or life- long monitoring and treatment. Most importantly, It is not caused due to consumption excess sugar, sweets and carbohydrates. It occurs as a result of deficiency in an important hormone called insulin which converts sugar into energy or saves as fuel for later use.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
MsHansa Mehta, Professional
The Prescription has articles that make very good reading. Excellent presentation. Well done.
DrVivekVir Singh, MDThe Newsletter has extremely useful information for readers. Great reading, please continue.
MrPrem Atari, Pharma ExpertGood newsletter which brings an array of Pharma News for the avid Prescription newsletter. Keep up the good work.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
